Agios Pharmaceuticals
AGIO
$36.34
Share price
-3.20%
Change (1 day)
41.35%
Change (1 year)
Categories
Market capitalization of Agios Pharmaceuticals (AGIO)
Market cap: $2.06 Billion
As of June 2024 Agios Pharmaceuticals has a market cap of $2.06 Billion. This makes Agios Pharmaceuticals the world's 4081th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Agios Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.06 B | 65.75% |
| 2023 | $1.24 B | -19.32% |
| 2022 | $1.54 B | -13.57% |
| 2021 | $1.78 B | -40.52% |
| 2020 | $3.00 B | -8.12% |
| 2019 | $3.26 B | 21.67% |
| 2018 | $2.68 B | -3.69% |
| 2017 | $2.78 B | 58.98% |
| 2016 | $1.75 B | -28.36% |
| 2015 | $2.44 B | -41.13% |
| 2014 | $4.15 B | 456.23% |
| 2013 | $0.74 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Agios Pharmaceuticals was reported to be:
$2.06 Billion
$2.06 Billion
$2.06 Billion
$2.06 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $162.40 B | 7,771.75% | 🇺🇸 USA |
 Eli Lilly LLY | $779.65 B | 37,689.91% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.92 B | 4,452.47% | 🇬🇧 UK |
 Xencor XNCR | $1.46 B | -28.99% | 🇺🇸 USA |
 Exelixis EXEL | $6.31 B | 206.24% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 590.91% | 🇺🇸 USA |